XML 93 R80.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information - Schedule of Business Segments (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Segment Reporting Information [Line Items]          
Net sales $ 2,301 $ 2,266 $ 7,325 $ 6,262  
Other (charges) gains, net (Note 14) (15) 0 (15) 3  
Operating profit (loss) 308 536 1,322 1,429  
Equity in net earnings (loss) of affiliates 73 44 189 110  
Depreciation and amortization 100 93 309 274  
Capital expenditures 123 [1] 123 [1] 369 [2] 309 [2]  
Goodwill and intangible assets, net 1,939   1,939   $ 2,147
Total assets 21,337   21,337   11,975
Increase (decrease) in accrued capital expenditures (16) 21 (31) 5  
Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 929 684 2,787 2,011  
Acetate Tow          
Segment Reporting Information [Line Items]          
Net sales 135 128 379 385  
Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales [3] 1,237 1,454 4,159 3,866  
Operating Segments | Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 929 684 2,787 2,011  
Other (charges) gains, net (Note 14) (14) 0 (14) 6  
Operating profit (loss) 114 91 404 344  
Equity in net earnings (loss) of affiliates 69 39 171 96  
Depreciation and amortization 43 35 134 105  
Capital expenditures 34 36 99 92  
Goodwill and intangible assets, net 1,544   1,544   1,714
Total assets 5,672   5,672   5,363
Operating Segments | Acetate Tow          
Segment Reporting Information [Line Items]          
Net sales 135 128 379 385  
Other (charges) gains, net (Note 14) 0 0 0 0  
Operating profit (loss) (3) 12 0 52  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Depreciation and amortization 10 10 31 29  
Capital expenditures 9 10 26 31  
Goodwill and intangible assets, net 152   152   154
Total assets 1,202   1,202   1,098
Operating Segments | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales 1,274 1,489 4,268 3,954  
Other (charges) gains, net (Note 14) 0 1 0 1  
Operating profit (loss) 315 517 1,243 1,284  
Equity in net earnings (loss) of affiliates 1 1 8 5  
Depreciation and amortization 43 44 130 128  
Capital expenditures 65 73 205 171  
Goodwill and intangible assets, net 243   243   279
Total assets 4,307   4,307   4,428
Corporate, Non-Segment | Other Activities          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 0  
Other (charges) gains, net (Note 14) (1) (1) (1) (4)  
Operating profit (loss) (118) (84) (325) (251)  
Equity in net earnings (loss) of affiliates 3 4 10 9  
Depreciation and amortization 4 4 14 12  
Capital expenditures 15 4 39 15  
Goodwill and intangible assets, net 0   0   0
Total assets 10,156   10,156   1,086
Eliminations          
Segment Reporting Information [Line Items]          
Net sales (37) [4] (35) [4] (109) [5] (88) [5]  
Other (charges) gains, net (Note 14) 0 0 0 0  
Operating profit (loss) 0 0 0 0  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Depreciation and amortization 0 0 0 0  
Capital expenditures 0 0 0 0  
Goodwill and intangible assets, net 0   0   0
Total assets 0   0   $ 0
Eliminations | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales $ 37 $ 35 $ 109 $ 88  
[1] Includes a decrease in accrued capital expenditures of $16 million and an increase of $21 million for the three months ended September 30, 2022 and 2021, respectively.
[2] Includes a decrease in accrued capital expenditures of $31 million and an increase of $5 million for the nine months ended September 30, 2022 and 2021, respectively.
[3] Excludes intersegment sales of $37 million and $35 million for the three months ended September 30, 2022 and 2021, respectively. Excludes intersegment sales of $109 million and $88 million for the nine months ended September 30, 2022 and 2021, respectively.
[4] Includes intersegment sales primarily related to the Acetyl Chain.
[5] Includes intersegment sales primarily related to the Acetyl Chain.